Lupron and Hypercoagulation - a phase IV clinical study of FDA data
Summary:
Hypercoagulation is reported as a side effect among people who take Lupron (leuprolide acetate), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Keppra, and have Cataplexy.
The phase IV clinical study analyzes which people have Hypercoagulation when taking Lupron. It is created by eHealthMe based on reports of 41,483 people who have side effects when taking Lupron from the FDA, and is updated regularly.
What is Lupron?
Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.
What is Hypercoagulation?
Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 400 drugs and 537 conditions by eHealthMe. Check the latest studies of Hypercoagulation.
41,483 people reported to have side effects when taking Lupron.
Among them, 18 people (0.04%) have Hypercoagulation.
Among these 18 people:
How long have people been on Lupron when they have Hypercoagulation? *
What is the gender of people who have Hypercoagulation when taking Lupron? *
What is the age of people who have Hypercoagulation when taking Lupron? *
What are other drugs people take besides Lupron? *
What are other side effects people have besides Hypercoagulation? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lupron and have Hypercoagulation?
- Check whether Hypercoagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lupron:
- Lupron (42,122 reports)
Hypercoagulation treatments and more:
- Hypercoagulation (4,011 reports)
How severe was Hypercoagulation and when was it recovered:
Expand to all the drugs that have ingredients of leuprolide acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lupron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypercoagulation:
- Hypercoagulation (400 drugs)
Browse all the conditions that are associated with Hypercoagulation:
- Hypercoagulation (537 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Lupron) and Lupron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin D and Gastrooesophageal Reflux Disease for Men aged 50-59 - 4 seconds ago
- Vitamin D and Gastro-Oesophageal Reflux Disease for Men aged 50-59 - 5 seconds ago
- Vitamin D and Reflux for Men aged 50-59 - 5 seconds ago
- Vitamin D and Heartburn for Men aged 50-59 - 5 seconds ago
- Vitamin D and Non-Cardiac Chest Pain for Men aged 50-59 - 5 seconds ago
- Vitamin D and Gerds for Men aged 50-59 - 6 seconds ago
- Vitamin D and Acid Reflux for Men aged 50-59 - 6 seconds ago
- Vitamin D and Reflux Esophagitis for Men aged 50-59 - 6 seconds ago
- Vitamin D and Pyrosis for Men aged 50-59 - 7 seconds ago
- Vitamin D and Peptic Esophagitis for Men aged 50-59 - 7 seconds ago